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ront Stroke, Back Stroke
he “Emerging” Interest of Stroke in
ranscatheter Aortic Valve Implantation*
asilis C. Babaliaros, MD
tlanta, Georgia
n the early period, transcatheter aortic valve implantation
TAVI) presentations always stirred the audience with both
xcitement and skepticism. Although many believed the
rocedure could be performed in the inoperable patient,
thers were concerned about the risk. Specifically, there was
lways a question from the audience regarding the low rate
f stroke in the initial French series (1,2). The explanation
as always the same: the pathology of the aortic valve is
hrink-wrapped. The disease is subendothelial and rarely
mbolizes from within the protective wrapper of the valve
uring dilation by balloon or stent. In fact, the stroke rate
as 2%, an astonishing result similar to that in balloon
ortic valvuloplasty series, and similar to or lower than that
n surgical series. It was suspected that most strokes oc-
urred because of manipulation of catheters in the ascending
orta, a minimal concern for the original implants that were
erformed antegrade transvenous.
See page 1133
In this issue of JACC: Cardiovascular Interventions,
ietlispach et al. (3) present a new device that is introduced
rom the radial artery to deflect debris away from the
nnominate artery and left carotid during TAVI. Because of
he numerous publications regarding successful TAVI with
0-day mortality now 10%, the attention has been di-
erted to improving the morbidity of the procedure. Hence,
e are back to the stroke issue. Is stroke a major concern
uring TAVI, and will protection devices reduce the risk?
Before commenting on these questions and the Nietlis-
ach et al. study (3), one needs to understand how often
linical strokes occur secondary to the treatment of aortic
tenosis. In the surgical literature, isolated aortic valve
eplacement has a stroke risk of 2% to 10% in octogenarians
4), and the risk depends significantly on comorbidities,
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ions or the American College of Cardiology.W
From the Andreas Gruentzig Cardiovascular Center, Emory University Hospital,
tlanta, Georgia. Dr. Babaliaros is a consultant for DirectFlow Medical and Symetis.scending aortic atheromata, and concomitant coronary
rtery bypass graft. For the cardiac surgeon, a distal protec-
ion device (Embol-X, Edwards Lifesciences Inc., Irvine,
alifornia) that is placed through the intra-aortic cannula
efore release of the aortic cross clamp has been investigated
5). Despite evidence that the filter collected fibro-
theromatous and platelet/fibrin particles in most patients,
he number of strokes in both filter and control groups were
ot different (2.5%). Post-operative renal insufficiency
not requiring dialysis) was, however, significantly less in
igh-risk patients using the filter. Despite these data, the
mbol-X device is not used routinely and axillary artery
annulation is used in patients with high-risk ascending
ortae.
In the TAVI literature, the stroke rate is 0% to 10% (6).
or a short period, transapical TAVI was touted as having
lower stroke risk because of less catheter manipulation in
he aorta, an observation that has not held up as larger series
ave been published. The increased stroke risk with
ransapical TAVI may be due to the higher comorbid
urden in these patients and cannulation of the apex with
ome catheter manipulation in the aorta. Guidelines for
nticoagulation have not been studied in either approach to
revent potential platelet/fibrin embolization.
Although the incidence of clinical stroke during treat-
ent of aortic stenosis performed in experienced centers
ay not be alarming, what may be alarming is the evidence
f subclinical events seen by magnetic resonance imaging
MRI). In a report by Kahlert et al. (7), 48% of patients
ollowing isolated surgical aortic valve replacement and 84%
ollowing TAVI had new foci of diffusion defects seen on
RI. In the surgical group, the foci were larger, and clinical
troke occurred in 1 patient (5%). In the TAVI group, these
efects were smaller and were not associated with stroke or
ecline in neurocognitive function. Data from Omran et al.
8) showed a 22% incidence of new MRI defects in patients
ith aortic stenosis after retrograde catheterization, with 3%
f patients suffering clinical stroke. So what is the signifi-
ance of the MRI foci? Does foci size correlate with clinical
troke? In the Kahlert et al. (7), study 80% had been
esolved by the 3-month follow-up MRI. Data regarding
ranscranial Doppler during TAVI has not been published.
his technique may prove to be even more sensitive than
RI and will also require clinical correlation.
How promising is a distal protection device for prevent-
ng stroke during TAVI? According to Nietlispach et al. (3),
uch a device is feasible, and its use adds only minimal time
o the procedure. Their filter cannot be overwhelmed
ecause particles are deflected rather than caught. Only 1
atient (25%) in their cohort developed a new MRI focus
hat was not associated with clinical stroke. Although these
RI data appears promising, does deflection favor the brain
t the expense of debris shuttled toward the distal organs?
ill other devices that capture debris be better in the long
r
p
s
f
d
T
t
R
D
C
v
R
1
2
3
4
5
6
7
8
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 1 1 , 2 0 1 0
N O V E M B E R 2 0 1 0 : 1 1 3 9 – 4 0
Babaliaros
Editorial Comment
1140un? Could this be the future for TAVI procedures and
erhaps all cardiac intervention cases? Like the Embol-X
tudy, a prospective trial is needed.
At the inception of TAVI, the issue of stroke was in the
orefront. Now with the emergence of new distal protection
evices, the issue of stroke has returned, not as a question of
AVI safety, but as another opportunity to perfect the
echnique. Front stroke, back stroke.
eprint requests and correspondence: Dr. Vasilis C. Babaliaros,
epartment of Cardiology, Emory University Hospital, 1364
lifton Road, Suite F606, Atlanta, Georgia 30322. E-mail:
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